Clinical Trial Update: Extracorporeal Cardiac Shock Wave Therapy (CSWT) for Treatment of Coronary Artery Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating extracorporeal cardiac shock wave therapy for coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Kunming Medical University | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED